The American Cancer Society's estimates for soft tissue sarcomas in the United States for 2025 are: About 13,520 new soft tissue sarcomas will be diagnosed (7,600 in males and 5920 in females). About ...
Mark Agulnik, MD, discusses the efficacy and adverse events in the DeFi trial for patients with desmoid tumors given nirogacestat. Mark Agulnik, MD, professor of Clinical Medicine, Vice Chair for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback